Switzerland
Roche breast cancer treatment wins US approval
The US Food and Drug Administration has approved Roche’s oral breast cancer treatment giredestrant in combination with everolimus for certain patients with advanced disease. Roche expects the drug to contribute to sales from 2027.
about 5 hours ago · 1 source
